3B Blackbio — 360° view

3B Blackbio, a company in the Healthcare Service Provider industry, reported revenue of ₹48 crore and net profit of ₹18 crore for the September 2026 quarter.

3B Blackbio (NSE: 3BBLACKBIO) closed at ₹1,305.10 on 20 Nov 2026. Its market capitalisation is ₹1,120 crore and it trades at 19.1 times earnings.

Share price
₹1,305.10 (20 Nov 2026)
Market cap
₹1,120 Cr (20 Nov 2026)
P/E
19.11 (20 Nov 2026)
Revenue
₹48 Cr (September 2026 quarter)
Net profit
₹18 Cr (September 2026 quarter)
ROCE
25.5% (FY26)
ROE
19.8% (FY26)
Book value
₹405 (FY26)
Dividend yield
0.38% (last 12 months to 20 Nov 2026)
52-week high / low
₹1,424.70 / ₹1,166.50 (20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Service Provider
Symbol
NSE: 3BBLACKBIO

Incorporated in 2011, 3B BlackBio Dx Ltd manufactures and exports PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents, and agrochemical-based products

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.